-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on CG Oncology, Raises Price Target to $115

Benzinga·11/17/2026 12:23:15
Listen to the news
HC Wainwright & Co. analyst Andres Y. Maldonado maintains CG Oncology (NASDAQ:CGON) with a Buy and raises the price target from $100 to $115.